form8k060407.htm
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of
1934
Date
of
Report (Date of earliest event
reported) May
28, 2007
PROTOKINETIX,
INC.
(Exact
name of registrant as specified in its charter)
Nevada
|
|
000-32917
|
|
94-3355026
|
(State
or other jurisdiction
|
|
(Commission
File Number)
|
|
(IRS
Employer
|
of
Incorporation)
|
|
|
|
Identification
Number)
|
|
|
Suite
1500-885 West Georgia Street
|
|
|
|
|
Vancouver,
British Columbia
|
|
|
|
|
V6C
3E8
|
|
|
|
|
(Address
of principal executive offices)
|
|
|
|
|
|
|
|
|
|
604-687-9887
|
|
|
|
|
(Registrant’s
Telephone Number)
|
|
|
_____________________________________________________________________________________
(Former
name or former
address, if changed since last report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Section
5 – Corporate Governance and Management
Item
5.02 Departure
of Directors or Principal Officers; Election of Directors; Appointment of
Principal
Officers.
On
May
28, 2007, Dr. John Todd resigned from his positions as a President, Chief
Executive Officer, Chief Financial Officer and Director of ProtoKinetix, Inc.
(the “Corporation”). Mr. Todd’s resignation was not because of any
disagreements with the Corporation on matters relating to its operations,
policies, disclosures and/or practices.
On
May
28, 2007, Dr. John Todd accepted his appointment to the non-executive position
of Director of Scientific Affairs.
On
May
28, 2007, our board of directors nominated Mr. Mark L. Baum, Esq. as Director
of
the Corporation
On
May
28, 2007, our board of directors appointed Mr. Mark L. Baum, Esq. to the
positions of interim President and Chief Executive Officer of the
Corporation.
Mark
L. Baum, Esq.
Mr.
Baum
is our interim President, interim Chief Executive Officer and one of our
Directors. He is not a full time employee and has other outside commitments.
In
2002, Mr. Baum founded Business Consulting Group Unlimited, Inc., a Southern
California-based merchant banking firm. Mr. Baum is a licensed attorney in
the
State of California and the principal attorney for The Baum Law Firm, P.C.
a
firm which he founded in 1998 and has been operating on an ongoing basis. Mr.
Baum has more than 11 years experience in creating, financing and growing
development stage enterprises in a variety of industries. Mr. Baum has
participated in numerous public spin-offs, venture fundings, private-to-public
mergers, corporate restructurings, asset acquisitions and asset divestitures.
Mr. Baum’s law practice focuses on securities laws and related issues for
small-cap and micro-cap publicly reporting companies.
Section
9 – Financial Statements and Exhibits
Item
9.01 Financial
Statements and Exhibits.
(c) Exhibits.
Number
|
|
Description
|
|
|
|
99.1
|
|
Resignation
letter of Dr. John Todd
|
|
|
|
99.2
|
|
Press
Release headlined: “ProtoKinetix Board of Directors Forms
Executive Search Committee”
|
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned, hereunto
duly authorized.
|
|
PROTOKINETIX,
INC.
|
|
/s/
|
Mark
L. Baum, Esq.
______________
|
|
By:
|
Mark
L. Baum, Esq.
|
|
Its:
|
President
and Chief Executive Officer
|